VolitionRX Ltd

Research VolitionRX Ltd (VNRX) on Bullrun: market cap USD 11.25M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerVNRX
• ExchangeNYSE MKT
• CountryUnited States
• SectorHealthcare
• IndustryMedical Devices
• CurrencyUSD
• Market capUSD 11.25M
• Financial periodFY2025
• RevenueUSD 1.73M
• Revenue growth40.0%
• Net income-USD 23.36M
• Free cash flow-USD 19.77M

Valuation Snapshot

latest market cap is USD 11.25M.

About VolitionRX Ltd

VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes.

Frequently asked questions

What is VolitionRX Ltd's market cap?

VolitionRX Ltd's market capitalization is USD 11.25M.

What does VolitionRX Ltd do?

VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals;